Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02527174
Title A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia (VIAC)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Alberta
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Volasertib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.